Axsome Therapeutics Inc (MEX:AZSM)
MXN 1519 0 (0%) Market Cap: 85.66 Bil Enterprise Value: 83.20 Bil PE Ratio: 0 PB Ratio: 42.15 GF Score: 39/100

Axsome Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 20, 2023 / 05:30PM GMT
Release Date Price: MXN1320
Eason Lee
Needham & Company, LLC - Analyst

Good afternoon, everyone. Welcome to our next session here with Axsome Therapeutics. I'm Eason Lee, one of the associates on the biotech research team here at Needham. And it's my pleasure to be hosting Herriot Tabuteau, who is the CEO of the company. (Conference Instructions)

Questions & Answers

Eason Lee
Needham & Company, LLC - Analyst

Herriot, thank you so much for joining today. And maybe to start off, it would be great if you could provide some introductory comments about the key elements of the company's strategy. What are some of the things we should be watching for in 2023?

Herriot Tabuteau
Axsome Therapeutics, Inc. - CEO

Great. Thank you so much, Eason, for having us present at the Needham Conference. We always enjoy presenting at Needham. So it's nice to continue that tradition, which I think we've been doing ever since we went public.

And right now, Axsome has entered into a very exciting phase for the company. If you step back,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot